Stephan Fuhrmann

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+ CD45RA+ CD27− T cells: the potential involvement of interleukin-7 in this process

Valentina Libri, Rita I. Azevedo, Sarah Jackson et al. · Immunology · 2011 · 115 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Nora Liebers, Johannes Duell, Donnacha Fitzgerald et al. · Blood Advances · 2021 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

Hartmut Goldschmidt, K. Elias, Jan Dürig et al. · Leukemia · 2020 · 66 citations

Medicine, Hematology, Oncology +9

KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis

Mohamad Jawhar, Konstanze Döhner, Sebastian Kreil et al. · Leukemia · 2019 · 39 citations · Full text

Life Sciences, Genetics, Oncology +15